论文信息 - Nanomedicine: is the wave cresting? - 字舞流文

Nanomedicine: is the wave cresting?

The field of nanomedicine has grown rapidly in recent years, but several issues are emerging that could constrain its future evolution, particularly if they are not appropriately acknowledged and the potential of nanomedicine is oversold.

Rudy Juliano | R. Juliano

[1] Eric P. Winer,et al. CALGB 40502/NCCTG N063H: Randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-paclitaxel (NP) or ixabepilone (Ix) with or without bevacizumab (B) as first-line therapy for locally recurrent or metastatic breast cancer (MBC). , 2012 .

[2] R. Duncan,et al. Nanomedicine(s) under the microscope. , 2011, Molecular pharmaceutics.

[3] Triantafyllos Stylianopoulos,et al. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. , 2011, Annual review of chemical and biomolecular engineering.

[4] V. Muzykantov,et al. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities , 2012, Science.

[5] V. Venditto,et al. Cancer nanomedicines: so many papers and so few drugs! , 2013, Advanced drug delivery reviews.